Title: Family Medicine – Women’s Health: STDs; Contraceptive Options; Coronary Artery Disease
Faculty: Herbert L. Muncie, Jr., M.D., Alyson N. Owen, M.D.
Original Release Date: July 1, 2019 Expiration Date: July 1, 2022
TOPIC 1: Treatment of Sexually Transmitted Infections.
Upon completion of this session, using the CDC Guidelines and the Cochrane Abstract Database, the participant should be able to: EBM,GL, COMP
- Determine the appropriate diagnostic testing for complaints suggestive of a sexually transmitted infection.
- Select the therapy for the commonly encountered sexually transmitted infections.
- Formulate the follow-up testing and evaluations for sexually transmitted infections.
- Recommend the therapeutic options for preventing herpes simplex infections.
TOPIC 2: Contraceptive Options – Helping Women Make an Informed Choice.
Upon completion of this session, using the ACOG Practice Guidelines and the Cochrane Abstract Database, the participant should be able to: EBM,GL, COMP
- Appraise the pharmacologic differences in oral contraceptives and their role in contraceptive efficacy.
- Formulate the treatment options for contraception other than oral contraceptives.
- Specify the relative and absolute contraindications to oral contraceptives.
- Relate the circumstances that would be eligible for emergency contraception and the appropriate emergency contraception method for each situation.
TOPIC 3: Women and CAD: Risk Factors and Treatment of Acute MI
Upon completion of this session, the participant should be able to: EBM, COMP
- Distinguish the different effects of risk factors on women and risk factors that are unique to women
- Appropriately assess cardiovascular risk and order appropriate screening tests
- Recognize the differences in the presentation of acute coronary syndromes in women
- Utilize evidence based therapies for the treatment of ACS in women
- The receipt for any incentive-associated purchase will designate the value of the gift card separately from the cost of the learning activity.
- This incentive may have implications on your tax reporting obligations. Any reimbursed amount must be declared as personal income for tax purposes.